Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic (IMPACCT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04979897 |
Recruitment Status :
Recruiting
First Posted : July 28, 2021
Last Update Posted : July 28, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Intensive care unit (ICU) survivors and their families frequently present mental, cognitive and physical impairments lasting years. The ongoing pandemic could affect the duration, variety, and severity of these impairments. Our aim is to determine the impact of the COVID-19 pandemic on the physical, mental, and cognitive health of survivors, the experience of their families and their treating healthcare professionals in the long-term.
This is a prospective, multicentre, mixed-methods cohort study in seven Chilean ICUs. The perceptions of family members regarding the ICU stay and the later recovery will be explored 3 months after discharge. Health care professionals will be invited to discuss the challenges faced during the pandemic using semi-structured interviews.
Condition or disease | Intervention/treatment |
---|---|
Covid19 Critical Care Postintensive Care Syndrome | Other: Intensive care unit stay during the COVID-19 pandemic |
Study Type : | Observational |
Estimated Enrollment : | 450 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic (IMPACCT COVID-19): a Prospective, Multicentre, Mixed-methods Cohort Study |
Actual Study Start Date : | October 5, 2020 |
Estimated Primary Completion Date : | November 2, 2021 |
Estimated Study Completion Date : | February 2, 2022 |

Group/Cohort | Intervention/treatment |
---|---|
Intensive care unit stay during high bed occupancy in the COVID-19 pandemic
Adult patients (≥18 years old) who are mechanically ventilated for at least 48 hours in one of the participating ICUs during a high bed occupancy in the pandemic
|
Other: Intensive care unit stay during the COVID-19 pandemic
Patients will be screened daily for a potential ICU discharge. Each site coordinator, which is a clinician physiotherapist responsible for the site, will check that the patient is delirium-free (CAM-ICU negative) and cooperative (i.e. using 5 standardised questions: open [close] your eyes; look at me; open your mouth and stick out your tongue; nod your head; raise your eyebrows when I have counted up to five) within 72 hours from ICU discharge. Every patient deemed eligible will be invited to participate through a face-to-face visit by the assigned evaluator, receiving verbal and written information about the study |
Intensive care unit stay during low bed occupancy in the COVID-19 pandemic
Adult patients (≥18 years old) who are mechanically ventilated for at least 48 hours in one of the participating ICUs during a low bed occupancy in the pandemic
|
Other: Intensive care unit stay during the COVID-19 pandemic
Patients will be screened daily for a potential ICU discharge. Each site coordinator, which is a clinician physiotherapist responsible for the site, will check that the patient is delirium-free (CAM-ICU negative) and cooperative (i.e. using 5 standardised questions: open [close] your eyes; look at me; open your mouth and stick out your tongue; nod your head; raise your eyebrows when I have counted up to five) within 72 hours from ICU discharge. Every patient deemed eligible will be invited to participate through a face-to-face visit by the assigned evaluator, receiving verbal and written information about the study |
- World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) [ Time Frame: 6 months after the ICU discharge ]The WHODAS 2.0 is a self-reported disability questionnaire based on the International Classification of Functioning, Disability, and Health (ICF). It includes 36 questions, organised under six domains (cognition, mobility, self-care, getting along, life activities and participation). Each question must be answered based on the perceived difficulty for performing activities using a 5-point scale (none, mild, moderate, severe and extreme)
- Clinical Frailty Scale [ Time Frame: Within 72 hours from ICU discharge ]The CFS evaluates specific domains including physical functioning, activities of daily living (ADL), instrumental ADL, assistance for personal care, comorbidities, and cognition to generate a frailty score using a 9-point scale ranging from 1 (very fit) to 9 (terminally ill). A score greater than 4 is considered fragile
- Medical Research Council Sum Score (MRC-SS) [ Time Frame: Within 72 hours from ICU discharge ]standardised examination of six muscle groups bilaterally (i.e. shoulder abduction, elbow flexion, wrist extension, hip flexion, knee extension and dorsiflexion)
- Functional Status Score for the Intensive Care Unit (FSS-ICU) [ Time Frame: Within 72 hours from ICU discharge ]The FSS-ICU is a mobility instrument to score the level of physical assistance required when performing five functional activities: rolling, transfer from supine to sit, sitting at the edge of the bed, transfer from sitting to stand, and walking
- Montreal Cognitive Assessment-Blind (MoCA blind) [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]The MoCA blind is a cognitive screening tool designed to detect cognitive dysfunction in five areas: memory, attention, language, abstraction and orientation. It requires 5 minutes to be completed
- Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]The HADS is an interviewer or self-administered questionnaire designed to identify anxiety and depressive symptoms in a wide variety of in-hospital patients, which requires between 2 and 5 minutes to be completed
- Impact of Events Scale-Revised (IES-R) [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]The IES-R is an interviewer or self-administered questionnaire designed to measure the subjective distress caused by traumatic events that has been validated for critical illness survivors
- European Quality of Life Health Questionnaire (EQ-5D-3L) [ Time Frame: 3 months, and 6 months after the ICU discharge ]The EQ-5D-3L is an interviewer or self-administered questionnaire of health status or health-related quality of life, including five domains: mobility, self-care, usual activities, pain/discomfort, anxiety/depression and global health state
- Employment status [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]The employment status will be evaluated using tailored questions regarding current occupation, working hours, and any changes to their employment situation as it has been used elsewhere
- Survival [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]Number of patients who survived
- Actigraphy [ Time Frame: 6 months after the ICU discharge ]To measure sedentary behaviour and physical activity
- Global Physical Activity Questionnaire (GPAQ) [ Time Frame: 6 months after the ICU discharge ]To measure sedentary behaviour and physical activity
- Consent rate [ Time Frame: Every month during one year ]Number of patients who agreed to participate divided by the number of patients who meet selection criteria
- Cohort retention rate [ Time Frame: Every month during one year ]Number of patients who can be contacted and evaluated

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Adult patients (≥18 years old)
- Mechanically ventilated for at least 48 hours
Exclusion Criteria:
- Unable to walk independently 2 weeks prior to ICU admission (with or without a gait aid)
- S5q < 5 or CAM-ICU positive within 72 hours after ICU discharge
- Patient who do not understand or speak Spanish
- Patient unable to communicate verbally
- Burn or severe trauma as admission diagnosis
- Any neurological disorder (i.e. spinal cord injury, stroke and brain tumours) as admission diagnosis
- Transferred to a non-participating study centre before ICU discharge assessment
- Recent prolonged hospital stay (extended by more than 3 months)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04979897
Contact: Felipe González-Seguel, MSc | 989540683 | feligonzalezs@udd.cl | |
Contact: Ana Castro-Ávila, PhD | anacastro@udd.cl |
Chile | |
Hospital Regional Dr. Leonardo Guzmán de Antofagasta | Recruiting |
Antofagasta, Chile | |
Contact: Yerko Villagra | |
Principal Investigator: Yerko Villagra | |
Sub-Investigator: Pilar Castro | |
Hospital San Pablo de Coquimbo | Recruiting |
Coquimbo, Chile | |
Contact: Eduardo González | |
Principal Investigator: Eduardo González | |
Clínica Alemana de Santiago | Recruiting |
Santiago, Chile | |
Contact: Agustín Camus-Molina, MSc | |
Principal Investigator: Agustín Camus-Molina, MSc | |
Sub-Investigator: Felipe González-Seguel, MSc | |
Clínica BUPA | Recruiting |
Santiago, Chile | |
Contact: Javiera Aguilera | |
Principal Investigator: Javiera Aguilera | |
Sub-Investigator: Joaquín Olave | |
Clínica INDISA | Recruiting |
Santiago, Chile | |
Contact: Felipe Muñoz-Muñoz, MSc | |
Principal Investigator: Felipe Muñoz-Muñoz, MSc | |
Hospital del Salvador | Recruiting |
Santiago, Chile | |
Contact: Camilo Cáceres | |
Principal Investigator: Camilo Cáceres | |
Sub-Investigator: Macarena Leiva-Corvalán | |
Hospital Metropolitano | Recruiting |
Santiago, Chile | |
Contact: Fernanda Baus | |
Principal Investigator: Fernanda Baus |
Principal Investigator: | Ana Castro-Ávila, PhD | Universidad del Desarrollo |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Ana Cristina Castro, Visiting lecturer, Universidad del Desarrollo |
ClinicalTrials.gov Identifier: | NCT04979897 |
Other Study ID Numbers: |
2020-78 |
First Posted: | July 28, 2021 Key Record Dates |
Last Update Posted: | July 28, 2021 |
Last Verified: | July 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Covid19 Critical care Postintensive Care Syndrome Rehabilitation Follow-up |
COVID-19 Respiratory Tract Infections Infections Pneumonia, Viral Pneumonia Virus Diseases |
Coronavirus Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Lung Diseases Respiratory Tract Diseases |